Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Cell Free DNA cfDNA Testing Market Report 2024

Cell Free DNA (cfDNA) Testing Global Market Report 2024 – By Product (Donor-Derived Cell-Free DNA, Circulating Cell-Free Tumor DNA, Cell-Free Fetal DNA), By Platforms (Next Generation Sequencing (NGS), rPCR And Multiplexed PCR, qPCR And dPCR, Other platforms), By Application (Oncology, Non-Invasive Prenatal Test (NIPT), Gynecology, Transplantation, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

Cell Free DNA (cfDNA) Testing Global Market Report 2024

Starting Price : $5000.00 | Pages : 175 | Published : July 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Cell Free DNA (cfDNA) Testing Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Cell Free DNA (cfDNA) Testing Market Definition

Cell-free DNA (cfDNA) testing is a non-invasive diagnostic method that analyzes DNA fragments circulating freely in the bloodstream. cfDNA testing is utilized in liquid biopsy procedures and allows for detecting and analyzing genetic mutations and alterations without the need for a traditional tissue biopsy.

The main products of the cell-free DNA (cfDNA) testing market are donor-derived cell-free DNA, circulating cell-free tumor DNA, and cell-free fetal DNA. Donor-derived cell-free DNA refers to cfDNA that comes from a transplanted donor organ or tissue and is present in the recipient's bloodstream. The various platforms include next-generation sequencing (NGS), rPCR and multiplex PCR, qPCR and dPCR, and other platforms, used for various applications such as oncology, NIPT (non-invasive prenatal test), gynecology, transplantation, and other disease conditions.

Cell Free DNA (cfDNA) Testing Market Segmentation

The cell free DNA (cfDNA) testing market covered in this report is segmented –

1) By Product: Donor-Derived Cell-Free DNA, Circulating Cell-Free Tumor DNA, Cell-Free Fetal DNA

2) By Platforms: Next Generation Sequencing (NGS), rPCR And Multiplexed PCR, qPCR And dPCR, Other platforms

3) By Application: Oncology, Non-Invasive Prenatal Test (NIPT), Gynecology, Transplantation, Other Applications

Global Cell Free DNA cfDNA Testing Market Size 2023 to 2028: Graph

Cell Free DNA (cfDNA) Testing Market Size 2024 And Growth Rate

The cell free DNA (cfDNA) testing market size has grown exponentially in recent years. It will grow from $7.07 billion in 2023 to $8.74 billion in 2024 at a compound annual growth rate (CAGR) of 23.6%. The growth in the historic period can be attributed to a rise in the adoption of cfDNA testing in prenatal care, increasing use of cfDNA analysis, growing interest in cfDNA research across various medical fields, and rise in gaining approvals from regulatory bodies.

Cell Free DNA (cfDNA) Testing Market Growth Forecast

The cell free DNA (cfDNA) testing market size is expected to see exponential growth in the next few years. It will grow to $20.63 billion in 2028 at a compound annual growth rate (CAGR) of 23.9%. The growth in the forecast period can be attributed to a shift towards personalized medicine, enhancements in healthcare infrastructure, aging population and increasing incidence of cancer, increasing adoption of precision medicine, increasing awareness and acceptance of liquid biopsy techniques, and increasing investment and funding in cfDNA research. Major trends in the forecast period include adoption of liquid biopsy technologies, advancements in Next-Generation Sequencing (NGS) technology, integration of AI and machine learning in cfDNA testing, development of point-of-care cfDNA tests, and implementation of cloud-based platforms for data storage and analysis.

Cell Free DNA (cfDNA) Testing Market Driver: Impact Of Rising Cancer Prevalence On The Cell-Free DNA (cfDNA) Testing Market

The rising prevalence of cancer is expected to propel the growth of the cell-free DNA (cfDNA) testing market going forward. Cancer is a complex group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. These cells can invade and destroy normal tissue and, if not controlled, can significantly harm the body. The prevalence of cancer is due to aging populations, shifts in lifestyle, environmental influences, and advancements in detection and diagnostic techniques. cfDNA testing detects genetic mutations associated with cancer at an early stage, often before symptoms appear. This allows for early intervention, improving patient outcomes and survival rates by identifying cancer in its initial stages. For instance, in February 2024, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, there are expected to be over 35 million new cases of cancer in 2050, a 77% increase over the projected 20 million cases in 2022. Therefore, the rising prevalence of cancer is driving the growth of the cell-free DNA (cfDNA) testing market.

Global Cell Free DNA (cfDNA) Testing Market Major Players

Major companies operating in the cell free DNA (cfDNA) testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, Bio-Techne Corporation, Natera Inc., Myriad Genetics Inc., NeoGenomics Laboratories Inc., Invitae Corporation, Foundation Medicine Inc., Guardant Health Inc., Integrated DNA Technologies Inc., Caris Life Sciences Inc., Twist Bioscience Corporation, Adaptive Biotechnologies Corporation, Biodesix Inc., Biocept Inc., Personal Genome Diagnostics Inc., Agena Bioscience Inc., Menarini Silicon Biosystems Inc., Circulogene Theranostics LLC

Global Cell Free DNA (cfDNA) Testing Market Trend: Labcorp Launches An Advanced Liquid Biopsy Test For Precision Oncology

Major companies operating in the cell-free DNA (cfDNA) testing market focus on developing innovative technologies, such as liquid biopsy tests that offer greater sensitivity, specificity, and efficiency in detecting cancer-related mutations and genetic alterations. Liquid biopsy tests refer to diagnostic procedures that allow oncologists to evaluate circulating cell-free DNA released by tumor cells, facilitating personalized, targeted therapy plans. For instance, in May 2023, Laboratory Corporation of America Holdings (Labcorp), a US-based life sciences company, launched Labcorp Plasma Focus, a new liquid biopsy test designed for patients with advanced or metastatic solid tumors. This test evaluates circulating cell-free DNA (cfDNA) released by tumor cells from a standard blood draw, making it minimally invasive and providing fast results. It enhances access to precision oncology by identifying clinically actionable biomarkers across several common cancers, such as non-small cell lung, colorectal, breast, esophageal, gastroesophageal junction, gastric cancers, and melanoma.

Cell Free DNA (cfDNA) Testing Market Merger And Acquisition: LabCorp Enhances Oncology Capabilities Through Acquisition Of Personal Genome Diagnostics Inc.

In February 2022, Laboratory Corporation of America Holdings (LabCorp), a US-based clinical healthcare company, acquired Personal Genome Diagnostics Inc. for an undisclosed amount. With the acquisition, LabCorp aims to advance its current liquid biopsy capabilities and broaden its range of cutting-edge next-generation sequencing (NGS)-based genomic profiling tools for cancer, placing it at the forefront of improving patient outcomes. Personal Genome Diagnostics Inc. is a US-based developer of precision oncology diagnostics, including cell-free DNA testing technology.

Regional Insights For The Global Cell Free DNA (cfDNA) Testing Market

North America was the largest region in the cell-free DNA (cfDNA) testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell free DNA (cfDNA) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cell free DNA (cfDNA) testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cell-free DNA (cfDNA) testing market consists of revenue entities earned by providing services such as liquid biopsy for cancer detection and monitoring, transplant rejection monitoring, and non-invasive prenatal testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell-free DNA (cfDNA) testing market also includes sales of products such as digital PCR systems, automated nucleic acid extraction systems, real-time PCR instruments, and library preparation systems for NGS. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The cell-free DNA (cfDNA) testing market research report is one of a series of new reports from The Business Research Company that provides cell-free DNA (cfDNA) testing market statistics, including cell-free DNA (cfDNA) testing industry global market size, regional shares, competitors with a cell-free DNA (cfDNA) testing market share, detailed cell-free DNA (cfDNA) testing market segments, market trends, and opportunities, and any further data you may need to thrive in the cell-free DNA (cfDNA) testing industry. This cell-free DNA (cfDNA) testing research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Cell Free DNA (cfDNA) Testing Market Report Forecast and Analysis
Report AttributeDetails
Market Size Value In 2024 $8.74 billion
Revenue Forecast In 2033 $20.63 billion
Growth Rate CAGR of 23.9% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Product: Donor-Derived Cell-Free DNA, Circulating Cell-Free Tumor DNA, Cell-Free Fetal DNA
2) By Platforms: Next Generation Sequencing (NGS), rPCR And Multiplexed PCR, qPCR And dPCR, Other platforms
3) By Application: Oncology, Non-Invasive Prenatal Test (NIPT), Gynecology, Transplantation, Other Applications
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, Bio-Techne Corporation, Natera Inc., Myriad Genetics Inc., NeoGenomics Laboratories Inc., Invitae Corporation, Foundation Medicine Inc., Guardant Health Inc., Integrated DNA Technologies Inc., Caris Life Sciences Inc., Twist Bioscience Corporation, Adaptive Biotechnologies Corporation, Biodesix Inc., Biocept Inc., Personal Genome Diagnostics Inc., Agena Bioscience Inc., Menarini Silicon Biosystems Inc., Circulogene Theranostics LLC
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Cell-Free DNA (cfDNA) Testing Market Characteristics

    3. Cell-Free DNA (cfDNA) Testing Market Trends And Strategies

    4. Cell-Free DNA (cfDNA) Testing Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Cell-Free DNA (cfDNA) Testing Market Size and Growth

    5.1. Global Cell-Free DNA (cfDNA) Testing Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Cell-Free DNA (cfDNA) Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Cell-Free DNA (cfDNA) Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Cell-Free DNA (cfDNA) Testing Market Segmentation

    6.1. Global Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Donor-Derived Cell-Free DNA

    Circulating Cell-Free Tumor DNA

    Cell-Free Fetal DNA

    6.2. Global Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Next Generation Sequencing (NGS)

    rPCR And Multiplexed PCR

    qPCR And dPCR

    Other platforms

    6.3. Global Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Oncology

    Non-Invasive Prenatal Test (NIPT)

    Gynecology

    Transplantation

    Other Applications

    7. Cell-Free DNA (cfDNA) Testing Market Regional And Country Analysis

    7.1. Global Cell-Free DNA (cfDNA) Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Cell-Free DNA (cfDNA) Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market

    8.1. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Cell-Free DNA (cfDNA) Testing Market

    9.1. China Cell-Free DNA (cfDNA) Testing Market Overview

    9.2. China Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Cell-Free DNA (cfDNA) Testing Market

    10.1. India Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Cell-Free DNA (cfDNA) Testing Market

    11.1. Japan Cell-Free DNA (cfDNA) Testing Market Overview

    11.2. Japan Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Cell-Free DNA (cfDNA) Testing Market

    12.1. Australia Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Cell-Free DNA (cfDNA) Testing Market

    13.1. Indonesia Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Cell-Free DNA (cfDNA) Testing Market

    14.1. South Korea Cell-Free DNA (cfDNA) Testing Market Overview

    14.2. South Korea Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Cell-Free DNA (cfDNA) Testing Market

    15.1. Western Europe Cell-Free DNA (cfDNA) Testing Market Overview

    15.2. Western Europe Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Cell-Free DNA (cfDNA) Testing Market

    16.1. UK Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Cell-Free DNA (cfDNA) Testing Market

    17.1. Germany Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Cell-Free DNA (cfDNA) Testing Market

    18.1. France Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.2. France Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.3. France Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Cell-Free DNA (cfDNA) Testing Market

    19.1. Italy Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.2. Italy Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.3. Italy Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Cell-Free DNA (cfDNA) Testing Market

    20.1. Spain Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.2. Spain Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.3. Spain Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Cell-Free DNA (cfDNA) Testing Market

    21.1. Eastern Europe Cell-Free DNA (cfDNA) Testing Market Overview

    21.2. Eastern Europe Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Cell-Free DNA (cfDNA) Testing Market

    22.1. Russia Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Cell-Free DNA (cfDNA) Testing Market

    23.1. North America Cell-Free DNA (cfDNA) Testing Market Overview

    23.2. North America Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Cell-Free DNA (cfDNA) Testing Market

    24.1. USA Cell-Free DNA (cfDNA) Testing Market Overview

    24.2. USA Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Cell-Free DNA (cfDNA) Testing Market

    25.1. Canada Cell-Free DNA (cfDNA) Testing Market Overview

    25.2. Canada Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Cell-Free DNA (cfDNA) Testing Market

    26.1. South America Cell-Free DNA (cfDNA) Testing Market Overview

    26.2. South America Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Cell-Free DNA (cfDNA) Testing Market

    27.1. Brazil Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Cell-Free DNA (cfDNA) Testing Market

    28.1. Middle East Cell-Free DNA (cfDNA) Testing Market Overview

    28.2. Middle East Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Cell-Free DNA (cfDNA) Testing Market

    29.1. Africa Cell-Free DNA (cfDNA) Testing Market Overview

    29.2. Africa Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Cell-Free DNA (cfDNA) Testing Market Competitive Landscape And Company Profiles

    30.1. Cell-Free DNA (cfDNA) Testing Market Competitive Landscape

    30.2. Cell-Free DNA (cfDNA) Testing Market Company Profiles

    30.2.1. F. Hoffmann-La Roche Ltd.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Thermo Fisher Scientific Inc.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Laboratory Corporation of America Holdings

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Quest Diagnostics Incorporated

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Agilent Technologies Inc.

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Cell-Free DNA (cfDNA) Testing Market Other Major And Innovative Companies

    31.1. Illumina Inc.

    31.2. Qiagen N.V.

    31.3. Exact Sciences Corporation

    31.4. Bio-Techne Corporation

    31.5. Natera Inc.

    31.6. Myriad Genetics Inc.

    31.7. NeoGenomics Laboratories Inc.

    31.8. Invitae Corporation

    31.9. Foundation Medicine Inc.

    31.10. Guardant Health Inc.

    31.11. Integrated DNA Technologies Inc.

    31.12. Caris Life Sciences Inc.

    31.13. Twist Bioscience Corporation

    31.14. Adaptive Biotechnologies Corporation

    31.15. Biodesix Inc.

    32. Global Cell-Free DNA (cfDNA) Testing Market Competitive Benchmarking

    33. Global Cell-Free DNA (cfDNA) Testing Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Cell-Free DNA (cfDNA) Testing Market

    35. Cell-Free DNA (cfDNA) Testing Market Future Outlook and Potential Analysis

    35.1 Cell-Free DNA (cfDNA) Testing Market In 2028 - Countries Offering Most New Opportunities

    35.2 Cell-Free DNA (cfDNA) Testing Market In 2028 - Segments Offering Most New Opportunities

    35.3 Cell-Free DNA (cfDNA) Testing Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Cell-Free DNA (cfDNA) Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Cell-Free DNA (cfDNA) Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 75: Thermo Fisher Scientific Inc. Financial Performance
  • Table 76: Laboratory Corporation of America Holdings Financial Performance
  • Table 77: Quest Diagnostics Incorporated Financial Performance
  • Table 78: Agilent Technologies Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Cell-Free DNA (cfDNA) Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Cell-Free DNA (cfDNA) Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 75: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 76: Laboratory Corporation of America Holdings Financial Performance
  • Figure 77: Quest Diagnostics Incorporated Financial Performance
  • Figure 78: Agilent Technologies Inc. Financial Performance

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

Read More

How Will The Nuclear Medicine Market Grow In 2022?

Read More

What Is The Pediatric Imaging Market Overview In 2022?

Read More

Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

Read More

The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

Read More

Cellular Health Screening Global Market Report 2024 – By Test Type (Single Test Panels, Telomere Tests, Oxidative Stress Tests, Inflammation Tests, Heavy Metals Tests, Multi-test Panels), By Sample Type (Blood, Saliva, Serum, Urine), By Collection Site (Home, Office, Hospital, Diagnostic Labs) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Carboxymethylcellulose (CMC) Global Market Report 2024 – By Grade (High Purity, Industrial, Technical), By Property (Thickening Agent, Stabilizer, Binder, Anti-Repository Agent, Lubricator, Emulsifier, Excipient), By Application (Food And Beverages, Oil And Gas, Cosmetics, Pharmaceuticals, Detergents, Paper Processing) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Autologous Cell Therapy Global Market Report 2024 – By Therapy (Autologous Stem Cell Therapy, Autologous Cellular Immunotherapies), By Source (Bone Marrow, Epidermis, Mesenchymal Stem Cells, Hematopoietic Stem Cells, Chondrocytes, Other Sources), By Application (Cancer, Neurodegenerative Disorders, Cardiovascular Disorders, Autoimmune Disorders, Orthopedics, Wound Healing, Other Applications), By End User (Hospitals And Clinics, Ambulatory Centers, Academics And Research, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Diffuse Large B-cell Lymphoma Therapeutics Global Market Report 2024 – By Drug Class (Cisplatin, Carboplatin, 5-fluorouracil, Docetaxel, Paclitaxel, Methotrexate, Other Drugs), By Therapy (Targeted Therapy, Immunotherapy, Chemotherapy, Other Therapies), By Route of Administration (Oral, Parenteral, Other Routes), By End User (Hospitals, Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Hepatocellular Carcinoma Drugs Global Market Report 2024 – By Type (Brachytherapy, Chemotherapy), By Drug Class (PD-1/PD-L1 Inhibitors, Tyrosine Kinase Inhibitors), By End User (Hospitals, Clinics, Cancer Rehabilitation Centers, Ambulatory Surgical Centers) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Mantle Cell Lymphoma Therapeutics Global Market Report 2024 – By Type (Combination Therapy, Monotherapy), By Mechanism of Action (Bruton Tyrosine Kinase Inhibitors, Alkylating Agents, Deoxyribonucleic Acid Synthesis Inhibitors, Microtubule Inhibitors, Monoclonal Antibodies, Other Mechanisms), By Route of Administration (Oral, Parenteral), By Application (Hospital, Research Institute, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Cellulite Treatment Global Market Report 2024 – By Procedure (Non-Invasive, Minimally Invasive, Topical), By Cellulite Type (Soft, Hard, Edematous), By End User (Hospitals, Cosmetic Surgery Centers, Specialized Dermatology Clinics) – Market Size, Trends, And Global Forecast 2024-2033

View Report

GMP Cell Therapy Consumables Global Market Report 2024 – By Product (Kits, Reagents or Molecular biology reagents, Growth Factors or Cytokines and Interleukins, Other Products), By Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, Other cell therapies), By Process (Cell Collection And Characterization or Sorting and Separation, Cell Culture and Expansion or Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution or Handling, Process Monitoring and Control or Readministration or Quality Assurance, Other Processes), By End-Use (Clinical, Commercial, Research) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the market?

Cell-free DNA (cfDNA) testing is a non-invasive diagnostic method that analyzes DNA fragments circulating freely in the bloodstream. cfDNA testing is utilized in liquid biopsy procedures and allows for detecting and analyzing genetic mutations and alterations without the need for a traditional tissue biopsy. For further insights on the market, request a sample here

How will the market drivers and restraints affect the market dynamics? What forces will shape the industry going forward?

The market major growth driver - The cell free DNA (cfDNA) testing market size has grown exponentially in recent years. It will grow from $7.07 billion in 2023 to $8.74 billion in 2024 at a compound annual growth rate (CAGR) of 23.6%. The growth in the historic period can be attributed to a rise in the adoption of cfDNA testing in prenatal care, increasing use of cfDNA analysis, growing interest in cfDNA research across various medical fields, and rise in gaining approvals from regulatory bodies. The cell free DNA (cfDNA) testing market size is expected to see exponential growth in the next few years. It will grow to $20.63 billion in 2028 at a compound annual growth rate (CAGR) of 23.9%. The growth in the forecast period can be attributed to a shift towards personalized medicine, enhancements in healthcare infrastructure, aging population and increasing incidence of cancer, increasing adoption of precision medicine, increasing awareness and acceptance of liquid biopsy techniques, and increasing investment and funding in cfDNA research. Major trends in the forecast period include adoption of liquid biopsy technologies, advancements in Next-Generation Sequencing (NGS) technology, integration of AI and machine learning in cfDNA testing, development of point-of-care cfDNA tests, and implementation of cloud-based platforms for data storage and analysis.. For further insights on the market, request a sample here

What is the forecast market size or the forecast market value of the market?

The cell free DNA (cfDNA) testing market size has grown exponentially in recent years. It will grow from $7.07 billion in 2023 to $8.74 billion in 2024 at a compound annual growth rate (CAGR) of 23.6%. The growth in the historic period can be attributed to a rise in the adoption of cfDNA testing in prenatal care, increasing use of cfDNA analysis, growing interest in cfDNA research across various medical fields, and rise in gaining approvals from regulatory bodies. The cell free DNA (cfDNA) testing market size is expected to see exponential growth in the next few years. It will grow to $20.63 billion in 2028 at a compound annual growth rate (CAGR) of 23.9%. The growth in the forecast period can be attributed to a shift towards personalized medicine, enhancements in healthcare infrastructure, aging population and increasing incidence of cancer, increasing adoption of precision medicine, increasing awareness and acceptance of liquid biopsy techniques, and increasing investment and funding in cfDNA research. Major trends in the forecast period include adoption of liquid biopsy technologies, advancements in Next-Generation Sequencing (NGS) technology, integration of AI and machine learning in cfDNA testing, development of point-of-care cfDNA tests, and implementation of cloud-based platforms for data storage and analysis. For further insights on the market, request a sample here

How is the market segmented?

The market is segmented
1) By Product: Donor-Derived Cell-Free DNA, Circulating Cell-Free Tumor DNA, Cell-Free Fetal DNA
2) By Platforms: Next Generation Sequencing (NGS), rPCR And Multiplexed PCR, qPCR And dPCR, Other platforms
3) By Application: Oncology, Non-Invasive Prenatal Test (NIPT), Gynecology, Transplantation, Other ApplicationsFor further insights on the market, request a sample here

Which region has the largest share of the market? What are the other regions covered in the report?

North America was the largest region in the cell-free DNA (cfDNA) testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell free DNA (cfDNA) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on the market, request a sample here.

Major companies operating in the cell free DNA (cfDNA) testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, Bio-Techne Corporation, Natera Inc., Myriad Genetics Inc., NeoGenomics Laboratories Inc., Invitae Corporation, Foundation Medicine Inc., Guardant Health Inc., Integrated DNA Technologies Inc., Caris Life Sciences Inc., Twist Bioscience Corporation, Adaptive Biotechnologies Corporation, Biodesix Inc., Biocept Inc., Personal Genome Diagnostics Inc., Agena Bioscience Inc., Menarini Silicon Biosystems Inc., Circulogene Theranostics LLC For further insights on the market, request a sample here.

What are the key trends in the market?

Major trend in the market - Labcorp Launches An Advanced Liquid Biopsy Test For Precision Oncology. For further insights on the market, request a sample here.

What are the major opportunities in the market? What are the strategies for the market?

For detailed insights on the major opportunities and strategies in the market, request a sample here.

How does the market relate to the overall economy and other similar markets?

For detailed insights on market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the industry?

For detailed insights on the mergers and acquisitions in the industry, request a sample here.

What are the key dynamics influencing the market growth? SWOT analysis of the market.

For detailed insights on the key dynamics influencing the market growth and SWOT analysis of the industry, request a sample here.